|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,544 JPY | +0.68% |
|
+2.19% | +5.63% |
Kaken Pharmaceutical Co., Ltd. reported earnings results for the full year ended March 31, 2023. For the full year, the company reported sales was JPY 72,984 million. Net income was JPY 5,440 million.
Basic earnings per share from continuing operations was JPY 144.8.
| 1st Jan change | Capi. | |
|---|---|---|
| +5.63% | 855M | |
| +30.38% | 684B | |
| +26.51% | 568B | |
| -4.36% | 361B | |
| +19.30% | 329B | |
| +3.73% | 284B | |
| +16.70% | 240B | |
| +8.78% | 208B | |
| -7.93% | 200B | |
| +7.68% | 166B |
KAKEN PHARMACEUTICAL CO., LTD. 